Keywords: obsessive-compulsive disorder; 5HT 2A polymorphism; association study; child and adolescent psychiatry Positive association between obsessive compulsive disorder (OCD) and the A-allele of the 5-HT 2A -receptor promoter polymorphism −1438G/A has recently been reported in adults. We performed an association analysis of this polymorphism in 55 children and adolescents with OCD and in 223 controls consisting of unrelated students. We detected statistically significant differences in genotype (P < 0.05) and allele frequencies (P < 0.05) between individuals with OCD and controls. In this, to our knowledge, first association study based on children and adolescents with OCD, we confirm an association of the A-allele of the 5-HT2A receptor gene with OCD.
Obsessive-compulsive disorder (OCD) is characterized by recurrent and intrusive thoughts (obsessions), usually accompanied by repetitive behaviours (compulsions). Insight is generally preserved into the senseless nature of the symptoms. 1 Family and twin studies provide evidence for a genetic basis of OCD. 2, 3 In 60% of patients OCD develops before the age of 25. The onset of the disease can even occur during childhood. 4 Pauls et al observed a higher familial loading of OCD in early onset cases, thus suggesting that genetic factors might be of greater importance in early onset OCD. 3 Serotonin (5-HT) dysfunction has been implicated in OCD and is thought to contribute to behavioural traits such as perfectionism and obsessiveness and is described as associated with anxiety and depression 5, 6 and vice versa. 7 Additionally, evidence is accumulating that 5-HT is involved in eating disorders. 8, 9 Obsessive, restrictive behaviour and perfection-seeking personality features are often found in anorexia nervosa (AN). [9] [10] [11] The implication of the serotonergic (5-HT) system in the pathophysiology of OCD is also supported by findings of central and peripheral abnormalities. An increase in central and peripheral levels of 5-HT and its metabolites has been measured in patients with OCD as compared to controls. 7, 12 For treatment of OCD, serotonin reuptake inhibitors (SRIs) like clomipramine, fluvoxamine, fluoxetine, sertraline, paroxetine and citalopram are uniquely efficacious. 7 In some studies pharmacological challenges with specific serotonin agonists such as methylchloro-phenylpiperazine (mCPP) were associated with transient exacerbation of obsessive symptoms. 13 In addition, the ability of metergoline to antagonize the behavioural effects of intravenous mCPP suggests that these responses are mediated by 5-HT1/5-HT2 receptors. 14 The −1438G/A promoter polymorphism of the 5-HT 2A gene seems to be implicated in other neuropsychiatric disorders such as schizophrenia, 15 seasonal affective disorder 16 and alcohol dependence. 17 Especially, AN restricting type has been found to be associated with the A-allele of the −1438G/A promoter polymorphism. 18 However, some studies were not able to confirm this association in AN. 19, 20 Traits, such as behavioural inhibition, high harm avoidance, and an obsessive concern with exactness and perfectionism persist after recovery from anorexia nervosa. These persistent symptoms raise the possibility that such traits also exist premorbidly. 9 It is thus possible that previous positive association results for AN are based mainly on a subgroup of patients with predominantly obsessive and perfectionist behaviours as part of their restrictive eating behaviour.
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In Japanese patients with alcohol disease an association of the −1438G-allele and alcohol dependence has been described. 17 The authors discussed that the Aallele could be associated with restrictive behaviour, as opposed to the G-allele, which could be associated with food and alcohol addiction. Aubert et al reported that the −1438 G/A polymorphism may influence food and alcohol intake in French overweights. 21 The 5-HT 2A A-allele was associated with lower energy intake and lower alcohol consumption in the two study samples. However, Preuss et al showed a significant association between the 5-HT 2A A-alleles and impulsive traits in German alcohol dependents. 22 In this study, we confirm a previously described association of the A-allele of the 5-HT 2A promoter −1438G/A polymorphism with OCD. 10 We genotyped 55 patients with OCD for the 5HT 2A polymorphism. Patients were recruited at four university departments for Child and Adolescent Psychiatry in Germany. All patients fulfilled the diagnostic criteria for OCD. 1 We also investigated an independent set of controls consisting of 223 unrelated German students. As shown in Tables 1 and 2 , frequencies of the genotypes of the 5-HT 2A promoter polymorphism (1438G/A) differ significantly between patients with OCD and controls (P = 0.046). Our finding is consistent with a previous study: Frequencies of the A-allele in our patients and controls (0.49 and 0.40; P = 0.048) were very similar to those reported previously for adult American patients and controls (0.50 and 0.41; P Ͻ 0.05, respectively). 10 In contrast to the results of Enoch et al, the genotype frequencies in our OCD-sample were also significantly different compared to the controls (P Ͻ 0.05). 10 In the study of Enoch et al 10 the mean age of onset, as retrospectively determined, was 14.8 ± 9.0 years of age for women and 13.1 ± 7.2 years of age for men. At the time of investigation the mean age was 41.7 ± 11.9 and 39.7 ± 9.2 years for female and male subjects, respectively. 23 In our study, the mean age of all patients was 12.11 ± 2.1 years. Hence, the results of Enoch et al 10, 23 and our own results pertain to early onset OCD. Recently, Enoch et al 23 described a sexually dimorphic relationship of the 5HT 2A -promoter polymorphism with OCD and found a higher frequency of the 1438A-allele in women. Therefore, we additionally performed an exploratory analysis for both sexes. For females (26 cases, 115 controls), the 1438A-allele was more common in OCD patients (0.54) than in controls (0.40; nominal P = 0.03): For males (29 cases, 108 controls) the −1438A-allele of the 5HT 2A was also more common in OCD patients (0.45) than in controls (0.41; nominal P = 0.31). To investigate whether the differences are limited to females or are relevant for both sexes, larger sample sizes are necessary. In contrast to the results of Enoch et al and those of our group, two other studies pertaining to another polymorphism in the 5HT 2A receptor gene (102T/C) 24, 25 which is closely linked to the 5-HT 2A promoter polymorphism, 26 did not find differences in allele frequencies between adult subjects with OCD and controls. One explanation for these divergent results could be differences in ages at onset of OCD.
Of all patients with OCD in our study, we observed one or more psychiatric comorbid diagnoses in 49.1% of patients including attention-deficit/hyperactivity disorder, anxiety disorders, mood disorders, eating disorders and tic disorders. Table 2 shows the data for the subgroups with and without comorbid disorders; We conclude that our data support an association between the −1438A allele of the 5-HT 2A promoter polymorphism and juvenile OCD. This constitutes preliminary evidence for either a direct effect of the polymorphism as a risk factor for OCD, or the existence of another polymorphism close to this polymorphic site. Despite the fact that this study is the second to find an association between the −1438A allele and OCD there is always a distinct possibility of false positive findings in case control studies due to population stratification. Therefore, further studies, eg linkage studies with affected sib pairs or larger pedigrees and transmission disequilibrium studies with case-parenttrios, need to be performed and should take age at onset into consideration.
Methods

Subjects and genotyping
The study sample comprised patients who had received in-patient treatment at the Departments of Child and Adolescent Psychiatry of the Universities of Wü rzburg, Marburg, Aachen or Freiburg. The patients and controls were all of German origin. All participants and, in case of minors, their parents gave written informed consent. The ethics committees of the Universities of Wü rzburg, Marburg, Aachen and Freiburg approved the study.
Exclusion criteria for patients were: lifetime history of psychotic disorders, Gilles-de-la-Tourette's disorder, autistic disorder, alcohol dependence and mental retardation (IQ Ͻ70). All patients fulfilled the diagnostic criteria for OCD according to DSM-IV. 1 To certify the criteria all patients were interviewed with: (a) the YaleBrown Obsessive Compulsive Scale or the Children's Yale-Brown Obsessive Compulsive Scale (Y-BOCS); 27 and (b) DIPS (children's version and parent's version). 28 For patients with additional disorders we required that OCD predated the onset of the comorbid disorder in the respective patient in order to obtain a more homogeneous sample. Our sample comprised 55 children and adolescents patients with OCD (mean age: 12.11 years, SD = 2.11 years, 29 boys and 26 girls). By using the DIPS, 28 diagnosed comorbid disorders were: attentiondeficit/hyperactivity disorder (19%), anxiety disorders (16.6%), mood disorders (11.9%), eating disorders (7.3%), tic disorders (4.8%). For 50.9% of the patients there was no comorbid diagnosis; 49.1% had one or more comorbid diagnoses.
Controls were taken from a sample of 77 normal and 146 underweight German students at the University of Marburg (for details see Hinney et al 29 ) . Among these students individuals with a lifetime occurence of AN or another eating disorder were excluded by screening with the Composite International Diagnostic Interview. 30 The mean age of controls was 25.20 years, and 51.5% of the controls were female.
Experimental procedures
DNA sampling and genotyping Genomic DNA was extracted from whole blood, the −1438 A/G polymorphism was analysed as reported previously. 19 Statistical analysis For the investigation of an increased frequency of the A-allele in individuals with OCD compared with underweight and normal weight controls we performed an asymptotic, one-sided Pearson Chi-square test. We followed a hierarchical test procedure. Thus, if the allele test was significant, we additionally investigated differences between genotypes with the one-sided Cochran-Armitage trend test for association.
